Hypertension treatment and control among 28 physician practices across the United States: Results of the hypertension: Assessment of treatment to target (HATT) study

Journal of Clinical Hypertension

Volumn 12, Issue 8, 2010, Pages 603-612

  Belletti, Daniel A ^a   Zacker, Christopher ^a   Wogen, Jenifer ^b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b MedMentis Consulting LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MEDICAL RECORD REVIEW; OBESITY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; UNITED STATES;

AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CONTINENTAL POPULATION GROUPS; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UNITED STATES;

EID: 77955238348     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2010.00311.x     Document Type: Article

References (14)

1. Chobanian A, Bakris G, Black H. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289:2560-2572.
2. Ong KL, Cheung BMY, Man YB. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 2007, 49:69-75.
3. Healthy People 2010. With Understanding and Improving Health and Objectives for Improving Health 2000, 2nd ed, Washington, DC, U.S. Government Printing Office
4. Heisler M, Hogan MM, Hofer TP. When more is not better: treatment intensification among hypertensive patients with poor medication adherence. Circulation 2008, 117:2884-2892.
5. Oliveria SA, Lapuerta P, McCarthy BD. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med 2002, 162:413-420.
6. Hyman D, Pavlik V, Vallbona C. Physician role in lack of awareness and control of hypertension. J Clin Hypertens (Greenwich) 2000, 2:324-330.
7. Andrade S, Gurwitz J, Field T. Hypertension management: the care gap between clinical guidelines and clinical practice. Am J Manag Care 2004, 10:481-486.
8. Shah BR, Hux JE, Laupacis A. Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians? Diabetes Care 2005, 28:600-606.
9. Brown JB, Nichols GA. Slow response to loss of glycemic control in type 2 diabetes mellitus. Am J Managed Care 2003, 9:213-217.
10. Giles T, Aranda JM, Suh DC. Ethnic/racial variations in blood pressure awareness, treatment, and control. J Clin Hypertens (Greenwich) 2007, 9:345-354.
11. Ogedegbe G. Barriers to optimal hypertension control. J Clin Hypertens 2008, 10:644-646.
12. Stephenson J. Noncompliance may cause half of antihypertensive drug " failures" JAMA 1999, 282:313-314.
13. Bramley TJ, Gerbino PR, Nightengale BS. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm 2006, 12:239-245.
14. Moser M. Physician or clinical inertia: what is it? Is it really a problem? And what can be done about it. J Clin Hypertens (Greenwich) 2009, 11:1-4.